Indole-3-Carbinol Inhibits the Growth of Endometriotic Lesions by Suppression of Microvascular Network Formation
article
OA: gold
CC0
⤵ 1 in-corpus citation
Abstract
Endometriosis represents an estrogen-dependent disorder with a complex pathophysiology. Phytochemicals are promising candidates for endometriosis therapy, because they simultaneously target different cellular processes involved in the pathogenesis of endometriosis. Herein, we analyzed whether indole-3-carbinol (I3C) suppresses the development of endometriotic lesions, which were surgically induced by fixation of uterine tissue samples (diameter: 2 mm) from female BALB/c donor mice to the peritoneum of recipient animals. The mice received either I3C or vehicle (control) by peroral administration once per day. Growth, cyst formation, cell proliferation, microvascularization and protein expression of the lesions were assessed by high-resolution ultrasound imaging, caliper measurements, histology, immunohistochemistry and Western blotting. I3C inhibited the vascularization and growth of endometriotic lesions without inducing anti-angiogenic and anti-proliferative side effects on reproductive organs. This was associated with a significantly reduced number of proliferating stromal and endothelial cells and a lower expression of the pro-angiogenic signaling molecules vascular endothelial growth factor receptor-2 (VEGFR2), phosphoinositide 3-kinase (PI3K) and phosphorylated extracellular signal-regulated kinase (pERK) within I3C-treated lesions when compared to controls. These findings indicate that I3C effectively inhibits endometriotic lesion formation in mice. Thus, further studies should clarify whether I3C may be also beneficial for the prevention and therapy of the human disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (68)
- Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis via openalex
- Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model via openalex
- Basic mechanisms of vascularization in endometriosis and their clinical implications via openalex
- CD206+ macrophage is an accelerator of endometriotic-like lesion via promoting angiogenesis in the endometriosis mouse model via openalex
- Clinical Management of Endometriosis via openalex
- Clinical Management of Endometriosis via openalex
- Cyclooxygenase-2 in Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis via openalex
- Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo via openalex
- Estrogen Stimulates Homing of Endothelial Progenitor Cells to Endometriotic Lesions via openalex
- High-Resolution Ultrasound Imaging via openalex
- <i>In vitro</i> and <i>in vivo</i> evaluation of the anti‐angiogenic actions of 4‐hydroxybenzyl alcohol via openalex
- Inhibitory effect of curcumin on angiogenesis in ectopic endometrium of rats with experimental endometriosis via openalex
- MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1β induced in human endometriosis stromal cells in vitro. via openalex
- Medical Management of Endometriosis via openalex
- Pathogenesis of Endometriosis: New Insights into Prospective Therapies via openalex
- Phytotherapy in endometriosis: an up-to-date review via openalex
- PI3K/AKT pathway is altered in the endometriosis patient’s endometrium and presents differences according to severity stage via openalex
- Puerarin Suppresses Invasion and Vascularization of Endometriosis Tissue Stimulated by 17β-Estradiol via openalex
- Reevaluating response and failure of medical treatment of endometriosis: a systematic review via openalex
- Resveratrol is a potent inhibitor of vascularization and cell proliferation in experimental endometriosis via openalex
- Role of Estrogen Receptor-β in Endometriosis via openalex
- Targeting sphingosine kinase‐1 with the low MW inhibitor SKI‐5C suppresses the development of endometriotic lesions in mice via openalex
- The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey via openalex
- The epidemiology of endometriosis via openalex
- The extracellular signal‐regulated kinase 1/2 triggers angiogenesis in human ectopic endometrial implants by inducing angioblast differentiation and proliferation via openalex
- The Modern Role of Reproductive Surgery via openalex
- Vascular development in endometriosis via openalex
- W2121836743 via openalex
- W2135414744 via openalex
- W2136601392 via openalex
- W2136981364 via openalex
- W2080003269 via openalex
- W2168828940 via openalex
- W2169396440 via openalex
- W2055303609 via openalex
- W2240701249 via openalex
- W2054861419 via openalex
- W2050605694 via openalex
- W2529543408 via openalex
- W2618025212 via openalex
- W2048608089 via openalex
- W2046885813 via openalex
- W2043620261 via openalex
- W2803175577 via openalex
- W2812157112 via openalex
- W2033801757 via openalex
- W2018982462 via openalex
- W2007864357 via openalex
- W2006760151 via openalex
- W3016339115 via openalex
- W3039708990 via openalex
- W3161227226 via openalex
- W3165785520 via openalex
- W1991224459 via openalex
- W3204346934 via openalex
- W1989463526 via openalex
- W1951528568 via openalex
- W4234160457 via openalex
- W1924670518 via openalex
- W6659435577 via openalex
- W6675454563 via openalex
- W2087861588 via openalex
- W6690285402 via openalex
- W2094531375 via openalex
- W2102073771 via openalex
- W2115415370 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-06-04T00:34:19.035172+00:00
License: CC0
· commercial use OK